First Generic Single-Dose Flu Medication Approved by FDA

The U.S. Food and Drug Administration has approved the first generic version of baloxavir marboxil, a single-dose influenza treatment. This development by Norwich Pharmaceuticals offers a more affordable option for treating acute uncomplicated flu and for post-exposure prevention in individuals aged five and older.